This grant opportunity supports research focused on developing and applying new biomarkers for diagnosing Alzheimer's disease and related dementias. Biomarkers are important tools for understanding these conditions and are vital for translating basic neuroscience research into clinical practice. The aim is to enhance clinical trials for therapies that modify these diseases by using these novel biomarkers.

Tremendous strides have been made in recent years in the study of the clinical neurobiology of Alzheimer’s disease (AD) and AD-related dementias (ADRD). Biomarkers play a key role in understanding AD/ADRD and are crucial to translating basic neuroscience research into clinical settings. Biomarke… Show More